4
Changes in Ownership
AXIM BIOTECHNOLOGIES, INC. Filed Acc 0001096906-22-000339
Options or other derivatives
- Director acquired 25,000 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Schroeder Blake Director | 2022-02-10 | Other acquisition · Convertible Note (Convertible into Common Stock) | +25,000 | $25,000.00 | $625,000,000 | 307,692 | D |
Loading xslF345X03/form4.xml…